Recession, risk and trade top 2020 pharma issues

2020 Life Sciences Audit Committee Outlook


Preparation, mitigation key issues facing pharma


Along with a looming recession and rising risks, pharmas will square off with tariffs and retaliations that have the potential to drive medium- or long-term structural change to the international trade order. Our outlook provides guidance as they wrestle with significant issues:


What’s in the report ?

  • Understanding how to prepare for and grow through a recession
  • Reconsidering investments to hold the line on revenue and headcount
  • Adequacy of skill sets to manage technology, growth and liability risks
  • Uncertainty about escalating supply chain and delivery costs
  • Short-term worries about legislation to reduce brand-name drug prices
  • Long-term concerns about China’s drive to own medical market share majority

“Prepare to solve 2020’s challenges by taking a bolder approach to focus on performance threats and tackle emerging and atypical risks that may not yet be recognized as bona fide threats.”


Meet our leader

Lisa Walkush

Lisa Walkush is a principal at Grant Thornton Advisors LLC. She boasts significant experience in enterprise-program management, customer-relationship management and operational excellence, as well as compliance, validation and technology-consulting services.

Philadelphia, Pennsylvania

  • Asset management
  • Banking
  • Energy
  • Healthcare
  • Hospitality & Restaurants
  • Insurance
  • Life sciences
  • Manufacturing, Transportation & Distribution
  • Media & entertainment
  • Not-for-profit & higher education
  • Private equity
  • Services
  • Construction & real estate
  • Retail & consumer brands
  • Technology, media & telecommunications
  • Transportation & distribution
Service Experience
  • Advisory